Copyright
©The Author(s) 2022.
World J Clin Cases. Jan 14, 2022; 10(2): 485-491
Published online Jan 14, 2022. doi: 10.12998/wjcc.v10.i2.485
Published online Jan 14, 2022. doi: 10.12998/wjcc.v10.i2.485
Table 2 Molybdenum target X-ray and magnetic resonance imaging diagnostic efficacies
| Diagnostic method | Sensitivity | Specificity | Accuracy |
| Molybdenum target X-ray | 79.37% (50/63) | 95.24% (60/63) | 87.30% (110/126) |
| MRI | 84.13% (53/63) | 96.83% (61/63) | 90.48% (114/126) |
| Combined methodology | 96.83% (61/63) | 96.83% (61/63) | 96.83% (122/126) |
| χ2/P value (Combined vs molybdenum target X-ray) | 7.568/0.006 | 0.000/1.000 | 6.572/0.010 |
| χ2/P value (Combined vs MRI) | 4.513/0.034 | 0.262/0.609 | 4.271/0.039 |
- Citation: Gu WQ, Cai SM, Liu WD, Zhang Q, Shi Y, Du LJ. Combined molybdenum target X-ray and magnetic resonance imaging examinations improve breast cancer diagnostic efficacy. World J Clin Cases 2022; 10(2): 485-491
- URL: https://www.wjgnet.com/2307-8960/full/v10/i2/485.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i2.485